Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-02-03

FDA Approved: NEXIUM 24HR CLEARMINIS — Supplemental Application (Haleon US Holdings LLC)

View source ↗

Summary

The FDA approved a supplemental application for NEXIUM 24HR CLEARMINIS (esomeprazole magnesium) by Haleon US Holdings LLC, adding a new formulation to the Nexiu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NEXIUM 24HR CLEARMINIS (Esomeprazole magnesium)

Snippet

SUPPL AP for NEXIUM 24HR CLEARMINIS (ESOMEPRAZOLE MAGNESIUM)